Literature DB >> 22028219

Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders.

Mathias Jucker1, Lary C Walker.   

Abstract

The misfolding and aggregation of specific proteins is a seminal occurrence in a remarkable variety of neurodegenerative disorders. In Alzheimer disease (the most prevalent cerebral proteopathy), the two principal aggregating proteins are β-amyloid (Aβ) and tau. The abnormal assemblies formed by conformational variants of these proteins range in size from small oligomers to the characteristic lesions that are visible by optical microscopy, such as senile plaques and neurofibrillary tangles. Pathologic similarities with prion disease suggest that the formation and spread of these proteinaceous lesions might involve a common molecular mechanism-corruptive protein templating. Experimentally, cerebral β-amyloidosis can be exogenously induced by exposure to dilute brain extracts containing aggregated Aβ seeds. The amyloid-inducing agent probably is Aβ itself, in a conformation generated most effectively in the living brain. Once initiated, Aβ lesions proliferate within and among brain regions. The induction process is governed by the structural and biochemical nature of the Aβ seed, as well as the attributes of the host, reminiscent of pathogenically variant prion strains. The concept of prionlike induction and spreading of pathogenic proteins recently has been expanded to include aggregates of tau, α-synuclein, huntingtin, superoxide dismutase-1, and TDP-43, which characterize such human neurodegenerative disorders as frontotemporal lobar degeneration, Parkinson/Lewy body disease, Huntington disease, and amyotrophic lateral sclerosis. Our recent finding that the most effective Aβ seeds are small and soluble intensifies the search in bodily fluids for misfolded protein seeds that are upstream in the proteopathic cascade, and thus could serve as predictive diagnostics and the targets of early, mechanism-based interventions. Establishing the clinical implications of corruptive protein templating will require further mechanistic and epidemiologic investigations. However, the theory that many chronic neurodegenerative diseases can originate and progress via the seeded corruption of misfolded proteins has the potential to unify experimental and translational approaches to these increasingly prevalent disorders.
Copyright © 2011 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22028219      PMCID: PMC3203752          DOI: 10.1002/ana.22615

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  108 in total

1.  An 'anatomical cascade hypothesis' for Alzheimer's disease.

Authors:  J Hardy
Journal:  Trends Neurosci       Date:  1992-06       Impact factor: 13.837

Review 2.  Axonal and transneuronal transport in the transmission of neurological disease: potential role in system degenerations, including Alzheimer's disease.

Authors:  C B Saper; B H Wainer; D C German
Journal:  Neuroscience       Date:  1987-11       Impact factor: 3.590

3.  Evidence for the experimental transmission of cerebral beta-amyloidosis to primates.

Authors:  H F Baker; R M Ridley; L W Duchen; T J Crow; C J Bruton
Journal:  Int J Exp Pathol       Date:  1993-10       Impact factor: 1.925

4.  Some speculations about prions, amyloid, and Alzheimer's disease.

Authors:  S B Prusiner
Journal:  N Engl J Med       Date:  1984-03-08       Impact factor: 91.245

5.  Seeding of normal Tau by pathological Tau conformers drives pathogenesis of Alzheimer-like tangles.

Authors:  Jing L Guo; Virginia M-Y Lee
Journal:  J Biol Chem       Date:  2011-03-03       Impact factor: 5.157

6.  Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease.

Authors:  P Brown; C J Gibbs; P Rodgers-Johnson; D M Asher; M P Sulima; A Bacote; L G Goldfarb; D C Gajdusek
Journal:  Ann Neurol       Date:  1994-05       Impact factor: 10.422

7.  Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease.

Authors:  H Crystal; D Dickson; P Fuld; D Masur; R Scott; M Mehler; J Masdeu; C Kawas; M Aronson; L Wolfson
Journal:  Neurology       Date:  1988-11       Impact factor: 9.910

8.  Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein.

Authors:  H Büeler; M Fischer; Y Lang; H Bluethmann; H P Lipp; S J DeArmond; S B Prusiner; M Aguet; C Weissmann
Journal:  Nature       Date:  1992-04-16       Impact factor: 49.962

Review 9.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

10.  Alzheimer's disease and transmissible virus dementia (Creutzfeldt-Jakob disease).

Authors:  P Brown; A M Salazar; C J Gibbs; D C Gajdusek
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

View more
  249 in total

Review 1.  Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.

Authors:  Seithikurippu R Pandi-Perumal; Ahmed S BaHammam; Gregory M Brown; D Warren Spence; Vijay K Bharti; Charanjit Kaur; Rüdiger Hardeland; Daniel P Cardinali
Journal:  Neurotox Res       Date:  2012-06-28       Impact factor: 3.911

2.  Cofactor molecules maintain infectious conformation and restrict strain properties in purified prions.

Authors:  Nathan R Deleault; Daniel J Walsh; Justin R Piro; Fei Wang; Xinhe Wang; Jiyan Ma; Judy R Rees; Surachai Supattapone
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-18       Impact factor: 11.205

3.  Critical role of intraneuronal Aβ in Alzheimer's disease: technical challenges in studying intracellular Aβ.

Authors:  Gunnar K Gouras; Katarina Willén; Davide Tampellini
Journal:  Life Sci       Date:  2012-06-19       Impact factor: 5.037

4.  Prion-like mechanisms in epileptogenesis.

Authors:  F Orzi; B Casolla; R Rocchi; F Fornai
Journal:  Neurol Sci       Date:  2012-07-10       Impact factor: 3.307

5.  Proceedings: cell therapies for Parkinson's disease from discovery to clinic.

Authors:  Rosa Canet-Aviles; Geoffrey P Lomax; Ellen G Feigal; Catherine Priest
Journal:  Stem Cells Transl Med       Date:  2014-08-22       Impact factor: 6.940

6.  ApoE4 Accelerates Early Seeding of Amyloid Pathology.

Authors:  Chia-Chen Liu; Na Zhao; Yuan Fu; Na Wang; Cynthia Linares; Chih-Wei Tsai; Guojun Bu
Journal:  Neuron       Date:  2017-12-06       Impact factor: 17.173

7.  β-amyloid impairs the regulation of N-methyl-D-aspartate receptors by glycogen synthase kinase 3.

Authors:  Yulei Deng; Zhe Xiong; Paul Chen; Jing Wei; Shengdi Chen; Zhen Yan
Journal:  Neurobiol Aging       Date:  2013-10-01       Impact factor: 4.673

Review 8.  α-Synuclein oligomers and clinical implications for Parkinson disease.

Authors:  Lorraine V Kalia; Suneil K Kalia; Pamela J McLean; Andres M Lozano; Anthony E Lang
Journal:  Ann Neurol       Date:  2012-12-07       Impact factor: 10.422

9.  Structural brain network imaging shows expanding disconnection of the motor system in amyotrophic lateral sclerosis.

Authors:  Esther Verstraete; Jan H Veldink; Leonard H van den Berg; Martijn P van den Heuvel
Journal:  Hum Brain Mapp       Date:  2013-03-01       Impact factor: 5.038

10.  Computational modeling of the relationship between amyloid and disease.

Authors:  Damien Hall; Herman Edskes
Journal:  Biophys Rev       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.